These findings demonstrate that the protective effect of HSD17B13 rs72613567:TA could be influenced by the coexistence of other genetic variants such as PNPLA3 and TM6SF2 and the presence of clinical risk factors including diabetes, obesity, and alcohol consumption. The gene discussed is PNPLA3; the disease is obesity disorder.